Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer
Conditions: Pancreatic Cancer Interventions: Drug: NMK89 Sponsors: Nihon Medi-Physics Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
Promoting Stress Management and Engagement in Introductory Physics Courses With Mindfulness and Relaxation
Conditions: Psychological Stress; Coping Skills; Emotions; Emotion Regulation Interventions: Behavioral: Mindfulness; Behavioral: Relaxation Sponsors: University of Pittsburgh; U.S. National Science Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2022 Category: Research Source Type: clinical trials
Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies.
Condition: Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer Intervention: Drug: Combination of Palbociclib and aromatase inhibitor (Letrozole or Anastrozole) Sponsors: International Cancer Research Group, United Arab Emirates; King Saud University Medical City, Riyadh, Saudi Arabia; Max-Planck-Institut für Quantenoptik (MPQ), and Faculty of Physics at Ludwig-Maximilians-Universität München (LMU), Garching, Germany; King Abdallah University for Scie nce and Technology (KAUST), Thuwal, Saudi Arabia. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 13, 2022 Category: Research Source Type: clinical trials
